12:00 AM
Feb 28, 2011
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

TiGenix proposes rights offering

TiGenix N.V. (Euronext:TIG), Leuven, Belgium
Business: Musculoskeletal, Gene/Cell therapy
Date announced: 2/25/11
Type: Rights offering
To be raised: About €15 million ($20.5...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >